Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Depression can affect anyone. It is common, and in many cases severe. These days, there are good treatments available, typically involving a combination of psychotherapy and medication.

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

The participants were implanted with a pacemaker-like device, under the skin in the chest that stimulated their left vagus ...

Neumora Therapeutics' (NMRA.O), opens new tab shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and pessimistic thoughts in a ...

The legalization of “magic” mushrooms comes as people increasingly turn to psychedelics to treat anxiety, depression and ...

Participants in clinic trial went from being unable to get out of bed to being productive and interacting with loved ones ...

(Bloomberg) -- Neumora Therapeutics Inc.’s shares plummeted the most on record after the company’s experimental drug for the ... as a promising new way to treat major depressive disorder ...